Pycnogenol May Help Reduce Symptoms and Frequency of Migraines
Pycnogenol is derived from the bark of the French maritime pine tree. Preliminary studies suggest it may improve inflammatory conditions and skin disorders due to its antioxidant and anti-inflammatory properties. Now a new study has found that Pycnogenol may help improve symptoms and decrease frequency of migraines.
Participants in the study included 67 people who suffered from migraines or moderate headaches. They participated in one of three interventions for 8 weeks: standard management using oral magnesium, riboflavin and lipoic acid; 150 mg of Pycnogenol daily in combination with standard management; the migraine medication topiramate. Participants recorded migraine episodes and ranked their symptoms.
Participants in the Pycnogenol group reported the greatest improvements in symptoms. They reported a 61% reduced frequency of migraines, compared to an 8% decrease in the standard management group and a 37% decrease in the topiramate group. The Pycnogenol group also reported a 39% decrease in migraine discomfort and a 41% decrease in disruption of daily life activities. In comparison, the standard management group reported decreases of 25% and 15% and the topiramate group reported decreases of 37% and 33%, respectively.
The study was conducted by researchers from Chieti-Pescara University. It was published in the June 2020 edition of the journal Panminerva Medica.